HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fibrin monomer could be a useful predictor of pulmonary embolism after total hip arthroplasty: preliminary report.

Abstract
We examined 17 total hip arthroplasty patients in order to develop a method for the predictive diagnosis of pulmonary embolism (PE) after joint arthroplasty. Scintigraphy revealed the presence of PE in 4 patients. Prothrombin time (PT), activated partial thromboplastin time (aPTT), antithrombin III (ATIII), and thrombin-AT III complex (TAT) did not show significant differences between patients with and without PE. D-dimer 7 days after surgery showed significant differences between patients with and without PE. Fibrin monomer (FM) increased sharply after surgery, and it was significantly different between the patients with and without PE immediately after surgery and 2 days after surgery. Our findings suggest the importance of FM in the predictive diagnosis of pulmonary embolism after total hip arthroplasty, and 40 microg/ml or higher levels with our measurement method could represent a high-risk condition.
AuthorsT Kubo, I Kitajima, A Makinodan, S Niratsuka, S Inoue, G Otsuka, S Ohashi, K Ueshima, Y Hirasawa
JournalJournal of orthopaedic science : official journal of the Japanese Orthopaedic Association (J Orthop Sci) Vol. 6 Issue 2 Pg. 119-22 ( 2001) ISSN: 0949-2658 [Print] Japan
PMID11484095 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fibrin Fibrinogen Degradation Products
  • fibrinmonomer
Topics
  • Aged
  • Arthroplasty, Replacement, Hip
  • Female
  • Fibrin Fibrinogen Degradation Products (analysis)
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications (diagnosis)
  • Predictive Value of Tests
  • Prognosis
  • Pulmonary Embolism (diagnosis, diagnostic imaging, etiology)
  • Radionuclide Imaging

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: